TECH CONNECTTurning Ideas into Opportunities
| |
| Monthly news & updates April 3, 2023
| |
|
| FY 2023STATISTICS
YEAR TO DATE
| |
| U.S. Patents
Issued
43
*includes end-user software and materials licenses along with conventional technology licenses
| |
|
Vanderbilt, VUMC reach 10th among private research universities, 24th overall in NSF Higher Education Research and Development survey
Vanderbilt University and Vanderbilt University Medical Center climbed seven spots in the prestigious survey by the National Science Foundation measuring annual research and development expenditures.
“Our upward leap in these important rankings sends a clear signal: we are already building tremendous momentum and moving swiftly ahead on the vision laid out in Discovery Vanderbilt, our initiative to catalyze discovery and dramatically expand our research funding and impact,” Provost C. Cybele Raver said. “This achievement reflects the hard work and creativity of faculty and staff across the university. And the most exciting part of it is that we are just getting started.”
The combined forces of Vanderbilt University and VUMC, with research and development expenditures exceeding $1 billion in 2021, ranked 10th among private research universities and 24th overall in R&D spending. It was the first time in more than a decade that Vanderbilt landed in the top 25 of the NSF’s annual Higher Education Research and Development Survey—reflecting Vanderbilt’s dedication to continuing excellence and increasing global impact. It was also 80 percent more than 2011’s amount and made up more than 62 percent of all expenditures by reporting institutions, public and private, in Tennessee.
The survey is “the primary source of information … for research and development expenditures within higher education institutions in the United States and outlying areas,” according to the National Science Foundation’s HERD Survey website, making it a good way to compare Vanderbilt with peer institutions.
Vanderbilt climbed to number 10 among private institutions the previous year, ranking above research institutions like Massachusetts Institute of Technology, Northwestern University, University of Southern California and Emory University.
| |
|
|
CTTC participates in VUSE panel about Vanderbilt’s entrepreneurial ecosystem
| |
In this panel, Vanderbilt University School of Engineering explores the university's entrepreneurial ecosystem with Charleson Bell, PhD, Director of Entrepreneurship, Biomedical Innovation, and I-Corps at Vanderbilt’s Wond’ry and Mr. George Wilson who is the Assistant Director of New Ventures at Vanderbilt University’s Center for Technology Transfer and Commercialization. We explore the innovation force amplifier Vanderbilt’s entrepreneurial ecosystem provides trainees that are coming to Vanderbilt to engineer technologies in surgery and intervention.
| |
Event AlertHow to Start a University Spinoff Biotech!Monday, April 21
VUMC's Brock Family Center for Applied Innovation and the Center for Technology Transfer & Commercialization are excited to announce the next presentation from the speaker series "From Concept to Commercialization: Translational and Entrepreneurial Journeys."
Martin (Marty) Moore is a founder and Chief Scientific Officer of Meissa Vaccines. Prior to cofounding Meissa, Marty was an Associate Professor at Emory University and director of the Emory Children’s Center for Childhood Infections and Vaccines (CCIV). He developed an RSV reverse genetics platform technology and novel strategies and methods for making vaccine candidates by synthetic biology. As applied to RSV vaccines, this technology was recognized as Emory University’s innovation of the year in 2013.
Marty has more than 70 publications in virology, is co-inventor of 20 RSV-related technologies, and is a frequent national/international lecturer on RSV and vaccines.
Join us for the in-person event on Monday, April 21 from 12pm-1pm in Light Hall room 214.
| |
| George Wilson and Charleson Bell host panel for Nashville CREST
| |
Nashville CREST aims to close to the opportunity divide by equipping Nashville residents and intentionally targeting historically and systemically marginalized communities with skills and support to pursue a dynamic career in the healthcare and biotech industries.
| |
| CTTC welcomes Cole Thomas
to the team
| |
Cole joined CTTC in March of 2023 and his responsibilities are focused on the completion, organization, and compliance of material transfer agreements and material licensing agreements. Cole graduated from Seattle University School of Law in May of 2022 and has prior legal and law firm experience working in dispute resolution, state and federal regulatory compliance, and conflicts of interests.
| |
| Four Vanderbilt Technologies Earn Patent Protection in March
| |
|
|
| |
|
Substituted Indole MCL-1 Inhibitors
| |
|
Hepatitis C Virus Gene Sequences and Methods of Use Therefor
| |
|
Multi-Articulated Catheters with Safety Methods and Systems for Image-Guided Collaborative Intravascular Deployment
| |
|
Methods for Fabricating Carbon Nanotube Arrays with a High Structural Factor
|
| |
|
Technology Spotlight:Nanostructured Molybdenum (IV) Disulfide (MoS2) Electrodes for use in Solar Cells
| |
Quantum dot sensitized solar cells (QDSSCs) are a widely studied system for harvesting light and converting it to electrical energy. Quantum dots (QDs) are an attractive photoabsorber because they have large absorption coefficients and their energy of absorption in the visible region can be tuned based on their size. Molybdenum (IV) disulfide (MoS2) is a naturally occurring semiconductor found in nature as the mineral molybdenite that can be synthesized from inexpensive, earth-abundant materials for use in solar cells.
Technology and IP Status:
A U.S. Patent has been issued. (9,496,094)
| |
Below is a sampling of the interactions that have taken place in our office and with our staff over the last month.
| |
Attended the Osage University Partners (OUP) Webinar on Patient Data Licensing
-
Attended a demo for a new patent searching tool
-
Attended the OUP webinar on 2023 Startup Financing Trends
-
Attended the Novartis Global Scholars Program quarterly meeting with Brent Ferrell of the Department of Medicine
-
Attended a Nashville Tech Council Networking Event
- Attended a Seminar on Cancer-Focused Natural Language Processing for Electronic Medical Records Data hosted by Vanderbilt Biomedical Informatics
- Attended Nashville Healthcare Council - Healthcare Workforce
-
Attended Voices of Entrepreneurship: Brittani Roberts
-
Met with potential investor concerning their new venture fund
-
Attended LST and TN Pharma Council/TN Med. Assoc. Reception
-
Attended LaunchTN Legislative Reception
-
Attended investor breakfast hosted by large venture firm
-
-
Attended the venture investor breakfast at ViVE Conference
-
Attended the NashTech x Innovation Week networking event
-
Attended the Nashville Entrepreneur Center open house and info session
-
Attended the Vanderbilt Law School Dean's Lecture Series on Police Reform
-
Attended a webinar on ChatGPT hosted by Vanderbilt
-
Attended Fund Tennessee program
-
Attended board meeting of the Nashville Technology Council Foundation
-
Attended board meeting of the Innovation Studio
-
Attended program: How One Founder is Scaling Her Mobility Startup
- As part of LaunchTN Innovation Week attended the legislative reception, presentations on the SBIR/STTR program and how it relates to both the NSF and DOD agencies, toured CET Life Science Incubator and the TSU Food Science research program
- Attended a Joint Steering Committee meeting with a company partnered with Steve Fesik from the Department of Biochemistry to develop anticancer compounds
- Attended meetings with venture capitalists from Solasta Ventures and Orange Grove Bio
- Attended quarterly call with a global pharmaceutical company for the progress of the project by Paul Brent Ferell and Alexander Bick from the Department of Medicine
- Attended a webinar organized by Osage University Partners on the topic "Patient Data Licensing"
- Attended a seminar by Susan Eagle of the Department of Medicine, and organized by the Brock Family Center for Applied Innovation and CTTC on the topic "From Concept to Commercialization: Translational and Entrepreneurial Journeys"
- Attended a webinar organized by Vanderbilt University Medical Center on the topic “A Discussion with Mark Cuban: How Cost Plus Drugs Is Innovating to Lower Prescription Drug Prices in America”
| |
- Executed an exclusive license agreement with a medical imaging company to commercialize technology developed by Richard Caprioli, Eric Spivey and David Anderson from the Mass Spectrometry Research Center
- Executed a materials license with a biotechnology research company for a mouse model developed by Eric Neilson formerly in the Department of Medicine
- Executed an exclusive license agreement with a proteomics-based company to commercialize technology developed by Justin Balko and Douglas Johnson from the Department of Medicine
| |
- Held initial discussions between Collin Howser, a resident at VUMC, and the CTTC Medical Director, Ken Holroyd, pertaining to a concept for a new medical device
- Met with Anh Hoang, a PhD graduate of the material science engineering program and venture capitalist, to discuss opportunities for investment in several Vanderbilt startups
- Met with a graduate student from the laboratories of Sharon Weiss regarding the potential for a startup company based on a recently disclosed sensor technology
- Facilitated a meeting between Michael Goldfarb from the Department of Mechanical Engineering and a local startup named LUCI for discussions on brain-computer interfaces for control
- Held a call with the founders of PATH EX to get an update on their development progress
- Facilitated Collaborative Discussion with AI Foundation and Vanderbilt faculty in the Humanities Department
- Introduced Vanderbilt portfolio company to a potential investor and participated in meeting
- Met with member of CTTC’s entrepreneur-in-residence group discussing potential project
- Discussions regarding Amazon Web Services Spring 2023 call for proposals related to generative AI research
- Continued discussions with a broadband company regarding smart cities, infrastructure, 5G technology and battery technology
- Met with a cybersecurity company regarding research being conducted at the Vanderbilt Institute for Software Integrated Systems
- Met with faculty to discuss potential Ancora proposal submissions
- Developed concept for a Therapeutic Advisory Board
- Provided consultation and met with a drug repurposing team for advice on a novel product concept
- Held license discussions with a startup company interested in commercializing the drug compound screening software developed by Vito Quaranta from the Department of Biochemistry
- Held meetings with colleagues from Duke University, the University of Michigan, the University of Arizona, and Columbia University to discuss how they could implement programs at their own institutions patterned after the Vanderbilt Innovation Ambassadors Program
| |
- Participated in a VICTR design studio in support of one of our researchers, Alex Langerman, and a new idea he has in the healthcare IT space
- Participated in the 2023 Scipreneur and SMARTTenn challenge for two separate technologies
- Hosted the V. P. of Science and Technology at CNBio, a Vanderbilt licensee, for discussions on product development and potential product launch from the technology licensed from Vanderbilt
- Led the spring meeting of our Innovation Ambassador Program, a group of 15 faculty members who serve as a liaison between their colleagues and various innovation programs across campus
- Led a working group with leaders from three other large research universities who are planning to launch an Ambassador program similar to the Vanderbilt program
- Toured lab space at Cumberland Emerging Technologies Life Science Incubator
- Hosted the University-Business Showcase on workforce development initiatives in partnership with Global Action Platform
- Participated in a panel discussion on Vanderbilt's Entrepreneurial Ecosystem hosted by Engineering in Surgery and Intervention
- Participated in Innovation Open Mic
- In support of the Corporate Partnership team, hosted a global automotive manufacturing company on campus to discuss workforce development, battery technology, data science/artificial intelligence with several faculty researchers
- Conducted Ancora Project Team meetings and Ancora project strategy meetings with 3DC team leads
- Hosted monthly Ancora business meetings with CTTC and Deerfield
- Taught a class on commercialization of research at an academic institution for the Vanderbilt IGP Course Intro to Clinical and Translational Research
| |
|
|
|
